Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer now displays the updated frontend revision (v3.5.4), replacing the prior revision (v3.5.3), indicating a frontend version update.
    Difference
    0.1%
    Check dated 2026-05-15T23:58:59.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-04-24T16:41:38.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.2 and no longer shows Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:22:16.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:15:48.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    New page revision notes and version identifiers were added, including Revision: v3.4.3 with date 2026-03-05 and additional dates 2027-02, 2026-03-03, and 2026-03. The previous revision v3.4.2 is listed under deletions.
    Difference
    0.4%
    Check dated 2026-03-11T14:50:05.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    A new site revision (v3.4.2) has been added, and the older revision (v3.4.1) along with the government funding status notice have been removed. These are administrative page maintenance updates and do not modify study details, eligibility criteria, or results.
    Difference
    0.4%
    Check dated 2026-02-11T05:35:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.